News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
BioNxt Solutions Inc. announces GMP manufacturing of Cladribine films & European CTA submission for MS drug candidate BNT23001, advancing toward human clinical study and comparative bioequivalence evaluation -